论文部分内容阅读
目的:观察口服阿托品治疗新生儿先天性不典型幽门肥厚狭窄与典型幽门肥厚狭窄的临床效果。方法:根据上消化道钡餐造影的情况(是否有典型“线样征”及“鸟嘴征”),将60例幽门肥厚狭窄患儿分为典型组与不典型组,分别口服阿托品治疗,分析其治疗效果。结果:不典型组治愈率为96.88%,而典型组治愈率仅为7.14%,两组差异有统计学意义。结论:口服阿托品治疗新生儿先天性不典型幽门肥厚狭窄的疗效较好,而对典型幽门肥厚狭窄的治疗效果较差。
Objective: To observe the clinical efficacy of oral atropine in the treatment of congenital atypical pyloric hypertrophy and pyloric hypertrophy and stenosis in neonates. Methods: According to the upper gastrointestinal barium meal angiography (whether there is a typical “line sign” and “beak sign”), 60 patients with pyloric stenosis were divided into typical group and atypical group, were orally Atropine treatment, analysis of its therapeutic effect. Results: The cure rate of atypical group was 96.88%, while the cure rate of typical group was only 7.14%. The difference between the two groups was statistically significant. CONCLUSION: Oral atropine treatment of neonatal congenital atypical pyloric hypertrophy stenosis better efficacy, while the typical pyloric hypertrophy and stenosis treatment less effective.